11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism

Langenbeck's Archives of Surgery

Volumn 395, Issue 7, 2010, Pages 963-967

  Hennings, J ^a,b   Sundin, A ^c,d   Hagg A ^a   Hellman, P ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Jamtland County Council   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenal; Dexamethasone; Metomidate; PET; Primary aldosteronism; Suppression

Indexed keywords

CARBON 11; DEXAMETHASONE; METOMIDATE; POTASSIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ETOMIDATE;

ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; CANCER STAGING; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; EPIDEMIOLOGY; FOLLOW UP; HYPERALDOSTERONISM; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; ORAL DRUG ADMINISTRATION; PATHOLOGY; SCINTISCANNING; TREATMENT OUTCOME; TUMOR VOLUME;

ADMINISTRATION, ORAL; ADRENOCORTICAL ADENOMA; ADULT; AGED; BIOPSY, NEEDLE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ETOMIDATE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERALDOSTERONISM; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SAMPLING STUDIES; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 78149465563     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-010-0681-7     Document Type: Article

References (22)

1. M Stowasser RD Gordon TG Gunasekera DC Cowley G Ward C Archibald BM Smithers 2003 High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non selective' screening of hypertensive patients J Hypertens 21 2149 2157 1:CAS:528:DC%2BD3sXos1amu74%3D 10.1097/00004872-200311000-00025 14597859 (Pubitemid 38296877)
2. P Mulatero M Stowasser KC Loh CE Fardella RD Gordon L Mosso CE Gomez-Sanchez F Veglio WF Young Jr 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents J Clin Endocrinol Metab 89 1045 1050 1:CAS:528:DC%2BD2cXisVWrtL8%3D 10.1210/jc.2003-031337 15001583 (Pubitemid 38368386)
3. JW Funder RM Carey C Fardella CE Gomez-Sanchez F Mantero M Stowasser WF Young Jr 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline J Clin Endocrinol Metab 93 9 3266 3281 1:CAS:528:DC%2BD1cXhtFChurrI 10.1210/jc.2008-0104 18552288
4. C Mattsson WF Young Jr 2006 Primary aldosteronism: diagnostic and treatment strategies Nat Clin Pract Nephrol 2 198 208 1:CAS:528: DC%2BD28XktFWhsrg%3D 10.1038/ncpneph0151 16932426 (Pubitemid 43787286)
5. E Letavernier S Peyrard L Amar F Zinzindohoué B Fiquet PF Plouin 2008 Blood pressure outcome of adrenalectomy in patients with hyperaldosteronism with or without unilaterlal adenoma J Hypertens 26 1816 1823 1:CAS:528:DC%2BD1cXpvFynsb4%3D 10.1097/HJH.0b013e3283060f0c 18698217
6. MK Walz R Gwosdz SL Levin PF Alesina AC Suttorp 2008 Metz KA et al Retroperitoneoscopic adrenalectomy in Conńs syndrome caused by adrenal adenoma or nodular hyperplasia World J Surg 32 5 847 853 10.1007/s00268-008- 9513-0 18343972
7. U Enberg C Volpe A Höög A Wedell LO Farnebo M Thorén 2004 Hamberger B Postoperative differentiation between unilateral adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of gene CYP11B2 Eur J Endocrinol 151 1 73 85 1:CAS:528:DC%2BD2cXmsFelu74%3D 10.1530/eje.0.1510073 15248825 (Pubitemid 39117367)
8. TC Pang C Bambach JC Monhagan S Siduh A Bune L Delbridge M Sywak 2007 Outcomes of laparoscopic adrenalectomy for hyperaldosteronism ANZ J Surg 77 9 768 773 10.1111/j.1445-2197.2007.04225.x 17685956 (Pubitemid 47222780)
9. I Gockel A Heintz M Polta T Juninger 2007 Long-term results of endoscopic adrenalectomy for Conńs syndrome Am Surg 73 2 174 180 17305298
10. Catena C, Coloussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna L, Sechi LA (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 14;168(1):80-85
11. ML White PG Gauger GM Doherty KJ Cho NW Thompson GD Hammer BS Miller 2008 The role of radiologic studies in the evaluation and management of primary hyperaldosteronism Surgery 144 6 926 933 10.1016/j.surg.2008.07.025 19040999
12. CP Lombardi M Rafaelli C De Crea V Rufini G Treglia R Bellantone 2007 Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery? Langenbecks Arch Surg 392 5 623 628 10.1007/s00423-006-0137-2 17242897 (Pubitemid 47246703)
13. R Zarnegar AI Bloom J Lee RK Kerlan Jr MW Wilson JM Laberge, et al. 2008 Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy? J Vasc Interv Radiol 19 1 66 71 10.1016/j.jvir.2007.08.022 18192469
14. M Bergström C Juhlin TA Bonasera A Sundin J Rastad G Akerstrom B Långström 2000 PET imaging of adrenal cortical tumours with the 11-hydroxylase tracer 11C-metomidate J Nucl Med 41 275 282 10688111
15. J Hennings Ö Lindhe M Bergström B Långström A Sundin P Hellman 2006 [11C]-Metomidate positron emission tomography of adrenocortical tumours in correlation with histopathological findings J Clin Endocrinol Metab 91 1410 1414 1:CAS:528:DC%2BD28XjvFOktr8%3D 10.1210/jc.2005-2273 16403816
16. G Zettinig M Mitterhauser W Wadsak A Becherer C Pirich H Vierhapper B Niederle R Dudczak K Kletter 2004 Positron emission tomography imaging of adrenal masses: 18F-fluorodeoxyglucose and the 11-hydroxylase tracer 11C-metomidate Eur J Nucl Med Mol Imaging 31 403 410 10.1007/s00259-004-1575-0 (Pubitemid 39222485)
17. 18F-FDG J Nucl Med 45 972 979 1:CAS:528:DC%2BD2cXnsFygtr8%3D 15181132
18. J Hennings P Hellman H Ahlström A Sundin 2009 Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas Eur J Radiol 69 2 314 323 10.1016/j.ejrad.2007.10.024 18082990
19. MD Gross B Shapiro RJ Grekin JE Freitas G Glazer WH Beierwaltes NW Thompson 1984 Scintigraphic location of adrenal lesions in primary aldosteronism Am J Med 77 839 844 1:STN:280:DyaL2M%2Fktl2juw%3D%3D 10.1016/0002-9343(84) 90521-7 6496538 (Pubitemid 15204861)
20. MD Gross B Shapiro 1989 Scintigraphic studies in adrenal hypertension Semin Nucl Med 19 122 143 1:STN:280:DyaL1M3it1Gjuw%3D%3D 10.1016/S0001-2998(89) 80007-8 2652311
21. M Nocadie-Calzada D Hulgo M Lambert O Ernst C Proye JL Wemeau X Marchandise 1999 Efficacy of iodine-131 6beta-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism Eur J Nucl Med 26 1326 1332
22. C Volpe U Enberg A Sjögren H Wahrenberg H Jacobsson O Törring B Hamberger M Thorén 2008 The role of adrenal scintigraphy in the preoperative management of primary aldosteronism Scand J Surg 97 248 253 1:STN:280:DC%2BD1cnitlCjsg%3D%3D 18812275